EUDA revenueFY2025$6.82M
- FY YoY
- +70.0%
EUDA revenue was $6.82M for fiscal 2025 (ended Dec 31, 2025), up 70.0% from fiscal 2024. It rose in 2 of the last 3 fiscal years.
EUDA Health Holdings Limited (EUDA) financials
For fiscal 2025 (ended Dec 31, 2025), EUDA Health Holdings Limited reported $6.82M of revenue and -$2.77M of net income.
- Revenue, FY2025
- $6.82M
- Revenue growth, YoY
- +70.0%
- Net income, FY2025
- -$2.77M
- Net margin
- -40.7%
- Free cash flow, FY2025
- -$2.50M
- EPS, diluted, FY2025
- -$1.48
- Cash
- $345.1K
- P/S
- 6.23
- Market cap
- $42.5M
FY2022FY2025
FY2022FY2025
FY2022FY2025
EUDA revenue and earnings growth
EUDA net incomeFY2025-$2.77M
EUDA net income was -$2.77M for fiscal 2025 (ended Dec 31, 2025), compared with -$15.36M in fiscal 2024.
EUDA EPSFY2025-$1.48
EUDA diluted EPS was -$1.48 for fiscal 2025 (ended Dec 31, 2025), compared with -$9.46 in fiscal 2024.
EUDA free cash flowFY2025-$2.50M
EUDA free cash flow was -$2.50M for fiscal 2025 (ended Dec 31, 2025), compared with -$2.13M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | $6.82M | $4.01M | $3.71M | $3.76M |
| Cost of revenue | $3.83M | $3.25M | $2.86M | $2.89M |
| Gross profit | $2.99M | $762.2K | $842.1K | $870.0K |
| Research and development | $249 | - | - | $17.2K |
| Selling, general and admin | $4.15M | $3.21M | $4.27M | $5.82M |
| Operating income | -$2.48M | -$17.34M | -$3.96M | -$12.22M |
| Interest expense | $228.6K | $44.9K | $23.2K | - |
| Pre-tax income | -$2.73M | -$17.64M | -$8.43M | -$25.03M |
| Income tax | $41.9K | -$4.4K | - | -$20.8K |
| Net income | -$2.77M | -$15.36M | -$10.04M | -$24.88M |
| EPS, basic | -$1.48 | -$9.46 | -$8.77 | -$41.40 |
| EPS, diluted | -$1.48 | -$9.46 | -$8.77 | -$41.40 |
| Diluted shares | 1.9M | 1.6M | 1.1M | 601,482.8 |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Cash and equivalents | $345.1K | $237.6K | $189.0K | $57.5K |
| Receivables | $242.6K | $146.2K | $237.5K | $192.9K |
| Inventory | $2.8K | $129.0K | - | - |
| Current assets | $1.04M | $762.9K | $723.4K | $25.03M |
| Goodwill | - | $0 | $0 | - |
| Total assets | $1.72M | $1.70M | $1.31M | $25.63M |
| Current liabilities | $5.84M | $4.14M | $8.72M | $29.12M |
| Total liabilities | $5.98M | $4.27M | $8.79M | $29.14M |
| Shareholders' equity | -$4.25M | -$2.55M | -$7.48M | -$3.51M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | -$2.43M | -$2.03M | -$2.92M | -$1.53M |
| Capital expenditures | $77.3K | $96.8K | - | $18.1K |
| Free cash flow | -$2.50M | -$2.13M | - | -$1.54M |
| Investing cash flow | -$104.5K | -$147.8K | - | -$268.2K |
| Financing cash flow | $2.55M | $2.32M | $2.35M | $2.49M |
| Depreciation and amortization | $195.2K | $173.2K | $119.3K | $172.0K |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue growth, YoY | 70.0% | 8.2% | -1.5% | - |
| Gross margin | 43.9% | 19.0% | 22.7% | 23.1% |
| Operating margin | -36.3% | -432.2% | -106.9% | -324.6% |
| Net margin | -40.7% | -382.9% | -270.9% | -661.1% |
| Free cash flow margin | -36.7% | -53.1% | - | -41.0% |
| Return on assets | -161.5% | -904.5% | -766.1% | -97.1% |
| Current ratio | 0.18 | 0.18 | 0.08 | 0.86 |
Income statement
| Line item | Mar 31, 2023 | Oct 31, 2022 | Mar 31, 2022 |
|---|---|---|---|
| Revenue | $1.70M | - | $2.67M |
| Cost of revenue | $1.30M | - | $1.40M |
| Gross profit | $403.6K | - | $1.27M |
| Research and development | - | - | $2.9K |
| Selling, general and admin | $1.98M | - | $824.9K |
| Operating income | -$1.98M | -$298.3K | $75.3K |
| Pre-tax income | -$2.41M | - | $230.8K |
| Income tax | $985 | - | $5.8K |
| Net income | -$2.41M | $201.0K | $222.6K |
| EPS, basic | -$2.40 | - | $0.40 |
| EPS, diluted | -$2.40 | - | $0.40 |
| Diluted shares | 1.0M | - | 462,666.65 |
Balance sheet
| Line item | Mar 31, 2023 | Oct 31, 2022 | Mar 31, 2022 |
|---|---|---|---|
| Cash and equivalents | $837.3K | $265.9K | - |
| Receivables | $1.59M | - | - |
| Current assets | $24.80M | $87.27M | - |
| Total assets | $25.48M | $87.27M | - |
| Current liabilities | $31.33M | - | - |
| Total liabilities | $31.42M | $5.02M | - |
| Shareholders' equity | -$5.95M | -$4.02M | $821.0K |
Cash flow
| Line item | Mar 31, 2023 | Oct 31, 2022 | Mar 31, 2022 |
|---|---|---|---|
| Operating cash flow | -$469.9K | -$123.8K | -$252.2K |
| Investing cash flow | - | - | -$29.3K |
| Financing cash flow | $525.3K | $196.1K | $331.4K |
Key ratios
Source: XBRL data EUDA Health Holdings Limited files with the SEC, latest filing dated Apr 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-20, first reported Apr 28, 2026.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
EUDA peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| EUDA | $6.82M | +70.0% | -$2.77M | -40.7% | $42.5M |
| BTSG | $15.25B | +26.0% | $410.27M | 2.7% | $13.76B |
| CHE | $2.66B | +5.2% | $282.40M | 10.6% | $7.00B |
| LFST | $1.68B | +22.6% | $71.91M | 4.3% | $5.55B |
| HIMS | $2.87B | +29.8% | -$190.84M | -6.7% | $5.35B |
| OPCH | $5.75B | +4.0% | $215.19M | 3.7% | $4.75B |
| PRVA | $2.43B | +19.2% | $36.08M | 1.5% | $3.14B |
| AVAH | $2.60B | +19.5% | $274.76M | 10.6% | $2.88B |
| ADUS | $1.50B | +11.5% | $111.05M | 7.4% | $2.28B |
EUDA FAQ
9 questionsWhat is EUDA revenue?
EUDA Health Holdings Limited (EUDA) reported $6.82M of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 70.0% from the year before.Is EUDA profitable?
No. EUDA Health Holdings Limited reported a net loss of $2.77M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does EUDA have?
EUDA Health Holdings Limited reported $345.1K in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is EUDA revenue growing?
EUDA Health Holdings Limited's revenue changed +70.0% in fiscal 2025, to $6.82M.What is EUDA gross margin?
EUDA Health Holdings Limited's gross profit was $2.99M on $6.82M of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 43.9%.What is EUDA free cash flow?
EUDA Health Holdings Limited generated -$2.50M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -$2.43M less capital expenditures.What is EUDA earnings per share?
Diluted earnings per share were -$1.48 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did EUDA last report financial results?
The latest statements here come from EUDA Health Holdings Limited's 20-F filed on Apr 28, 2026, covering the period ended Dec 31, 2025.Where does this EUDA financial data come from?
Quantisnow builds these statements from the structured XBRL data EUDA Health Holdings Limited files with the SEC. It is provided for information only and is not investment advice.